Claudio Carini Md Frcpath

FAQ About Claudio Carini Md Frcpath

• What is Claudio Carini Md Frcpath's address?

  Claudio Carini Md Frcpath is located at
  London, London, United Kingdom

• What is Claudio Carini Md Frcpath's job title?

  Claudio Carini Md Frcpath is a
  Claudio Carini MD, PhD, FRCPath Over 20 years of experience in drug development, personalized medicine, experimental medicine, biomarkers. Project leadership and portfolio management, prioritization, and scientific strategy. Recognized for deep industry experience, innovation, results-oriented, ability to deliver value products and wide experience across multiple therapeutic areas ). Noted for his excellent mentoring capacity and interpersonal skills to enhance team trust as well as the ability to solve problems and lead teams by example. Responsible for over 70 projects that led to the development of compounds. Dr. Carini received his MD in Italy and his Ph.D. from the University College of London (UCL). Postgraduate training included Internal Medicine internship, and residencies in Respiratory Medicine and Allergy and Clinical Immunology. He has also been awarded a membership of the Royal College of Pathologists, London. Dr. Carini is an H. Faculty at the King's College School of Medicine, London, UK. Formerly the Global Head Clinical Immunology and Biomarkers at Pfizer. Previously held faculty positions at Harvard, Johns Hopkins, UCL, Rome and senior roles at Wyeth, Novartis, Fresenius and Roche. Dr. Carini is also serving in national and international scientific boards: F-NIH Biomarkers Consortium Cancer, Inflammation & Immunology and Neuroscience Steering Committees MRC, UK) “Inflammation/ Immunology Initiative - UK RA Consortium, Steering Committee MRC, (UK) “Stratified Medicine, SLE Consortium, Steering Committee IMI, ABIRISK, European Union/EFPIA” Board of Directors The PML Consortium, Board of Director Over 200 papers in peer reviewed journals. Co-edited 3 books in the field of Personalized Medicine. Specific TAs expertise: Translational Med., Experimental Med. Immunology, Transplantation, Immunooncology, Respiratory Medicine, Autoimmune, Gastrointestinal and Neurological Diseases, Dermatology. Fnih The Biomarkers Consortium

• What industry does Claudio Carini Md Frcpath currently work in?

  Claudio Carini Md Frcpath currently works in the
  Fnih The Biomarkers Consortium

• What is Claudio Carini Md Frcpath's area of expertise?

  Claudio Carini Md Frcpath specializes in
  Claudio Carini MD, PhD, FRCPath Over 20 years of experience in drug development, personalized medicine, experimental medicine, biomarkers. Project leadership and portfolio management, prioritization, and scientific strategy. Recognized for deep industry experience, innovation, results-oriented, ability to deliver value products and wide experience across multiple therapeutic areas ). Noted for his excellent mentoring capacity and interpersonal skills to enhance team trust as well as the ability to solve problems and lead teams by example. Responsible for over 70 projects that led to the development of compounds. Dr. Carini received his MD in Italy and his Ph.D. from the University College of London (UCL). Postgraduate training included Internal Medicine internship, and residencies in Respiratory Medicine and Allergy and Clinical Immunology. He has also been awarded a membership of the Royal College of Pathologists, London. Dr. Carini is an H. Faculty at the King's College School of Medicine, London, UK. Formerly the Global Head Clinical Immunology and Biomarkers at Pfizer. Previously held faculty positions at Harvard, Johns Hopkins, UCL, Rome and senior roles at Wyeth, Novartis, Fresenius and Roche. Dr. Carini is also serving in national and international scientific boards: F-NIH Biomarkers Consortium Cancer, Inflammation & Immunology and Neuroscience Steering Committees MRC, UK) “Inflammation/ Immunology Initiative - UK RA Consortium, Steering Committee MRC, (UK) “Stratified Medicine, SLE Consortium, Steering Committee IMI, ABIRISK, European Union/EFPIA” Board of Directors The PML Consortium, Board of Director Over 200 papers in peer reviewed journals. Co-edited 3 books in the field of Personalized Medicine. Specific TAs expertise: Translational Med., Experimental Med. Immunology, Transplantation, Immunooncology, Respiratory Medicine, Autoimmune, Gastrointestinal and Neurological Diseases, Dermatology.

• Which languages does Claudio Carini Md Frcpath speak? 

  Claudio Carini Md Frcpath speaks the following languages:
  No languages available.

• Which industries has Claudio Carini Md Frcpath previously worked in?   

  Claudio Carini Md Frcpath has prior experience in the following industries:
  Pml Consortium , F Nih Biomarker Consortium , Pfizer , Fresenius , Mds , Hoffmann La Roche

• What is Claudio Carini Md Frcpath’s work experience?  

  Claudio Carini Md Frcpath has the following professional experience:
  Fnih The Biomarkers Consortium , Oxfordbiodynamics , Medical Research Council , Kings College School Of Medicine London , Innovative Medicines Initiative , Kings College School Of Medicine , Pml Consortium , Medical Research Council Ra Map Consortium , F Nih Biomarker Consortium , Pfizer , Boston Biotech Clinical Research Consulting , Fresenius , Mds , Hoffmann La Roche .

• How can I find Claudio Carini Md Frcpath on LinkedIn?  

  You can view Claudio Carini Md Frcpath’s
  LinkedIn profile at LinkedIn URL.

• What are Claudio Carini Md Frcpath’s work email addresses?  

  Claudio Carini Md Frcpath’s work email addresses are
  [email protected] .

• What company does Claudio Carini Md Frcpath work for?  

  Claudio Carini Md Frcpath works at
  Fnih The Biomarkers Consortium